TrialThe international journal of neuropsychopharmacology2021
Esketamine Nasal Spray for Rapid Reduction of Depressive Symptoms in Patients With Major Depressive Disorder Who Have Active Suicide Ideation With Intent: Results of a Phase 3, Double-Blind, Randomized Study (ASPIRE II).
Dawn F Ionescu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
116 papers cite itlatest 60 shown
this paperpooled ittrialcites it